| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |